WHO ICTRP trial
Analgesic effect of intravenous lidocaïne and its mechanisms in patients…
CTIS2023-508224-35-01 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-508224-35-01 |
|---|---|
| Public title | Analgesic effect of intravenous lidocaïne and its mechanisms in patients suffering from chronic inflammatory bowel disease (IBD) with abdominal pain. |
| Scientific title | Analgesic effect of intravenous lidocaïne and its mechanisms in patients suffering from chronic inflammatory bowel disease (IBD) with abdominal pain. |
| Primary sponsor | CHU De Liege |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Belgium |
| Conditions | Inflammatory Bowel disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Linisol 1 %, solution injectable, Product Code:PRD5359608, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: NaCl 0,9 % B. Braun, solution pour perfusion, Product Code:PRD5372764… |
| Registration date | Apr 25, 2024 |
| Target size | 80 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: